The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer

Ovarian cancer (OV) is the leading cause of death in gynecological cancer. The dysregulation of N6-methyladenosine (m6A) modification is commonly found in cancers. However, there is a lack of research into m6A RNA methylation regulators in OV. The RNA-Seq of 379 OV tissues and 88 healthy ovarian tis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of translational medicine 2022-01, Vol.10 (2), p.59-59
Hauptverfasser: Zhu, Wenjing, Zhao, Long, Kong, Beihua, Liu, Ying, Zou, Xin, Han, Tongqin, Shi, Yongmei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Ovarian cancer (OV) is the leading cause of death in gynecological cancer. The dysregulation of N6-methyladenosine (m6A) modification is commonly found in cancers. However, there is a lack of research into m6A RNA methylation regulators in OV. The RNA-Seq of 379 OV tissues and 88 healthy ovarian tissues was downloaded from The Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) databases, respectively. A Gene Ontology (GO) functional analysis was performed to verify the function of m6A RNA methylation regulators. Kaplan-Meier (K-M) curves and the log-rank (Mantel-Cox) test were used for the survival analysis. A Cox regression analysis was used to identify the genes related to overall survival (OS) and build the prediction model. m6A RNA methylation regulators were dysregulated in OV tissues compared with normal tissues (P
ISSN:2305-5839
2305-5839
DOI:10.21037/atm-21-6462